Skip to main content
SpringerLink
Log in

Serial septal branch assessment in hypertrophic obstructive cardiomyopathy

New echocardiographic contrast agent for alcohol septal ablation

Serielle Beurteilung von Septalästen bei hypertropher obstruktiver Kardiomyopathie

Neues Echokontrastmittel für die septale Alkoholablation

  • Case study
  • Published:
Herz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Gersh BJ, Maron BJ, Bonow RO et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 58(25):e212–e260

    Article  PubMed  CAS  Google Scholar 

  2. Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346(8969):211–214

    Article  PubMed  CAS  Google Scholar 

  3. Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 98(22):2415–2421

    Article  PubMed  CAS  Google Scholar 

  4. Faber L, Ziemssen P, Seggewiss H (2000) Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. J Am Soc Echocardiogr 13(12):1074–1079

    Article  PubMed  CAS  Google Scholar 

  5. Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42(9):1687–1713

    Article  PubMed  Google Scholar 

  6. Rigopoulos AG, Seggewiss H (2011) A decade of percutaneous septal ablation in hypertrophic cardiomyopathy. Circ J 75(1):28–37

    Article  PubMed  Google Scholar 

  7. Angelini P (2007) The “1st septal unit” in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience. Tex Heart Inst J 34(3):336–346

    PubMed Central  PubMed  Google Scholar 

  8. Singh M, Edwards WD, Holmes DR Jr et al (2001) Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc 76(8):799–802

    Article  PubMed  CAS  Google Scholar 

  9. Faber L, Seggewiss H, Ziemssen P, Gleichmann U (1999) Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area. Catheter Cardiovasc Interv 47(4):462–466

    Article  PubMed  CAS  Google Scholar 

  10. Faber L, Seggewiss H, Welge D et al (2004) Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Eur J Echocardiogr 5(5):347–355

    Article  PubMed  Google Scholar 

  11. Pfeiffer B, Rigopoulos A, Seggewiss H (2012) Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent. Dtsch Med Wochenschr 137(41):2093–2096

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. Medizinische Klinik 1, Leopoldina Krankenhaus Schweinfurt, Gustav-Adolf-Str. 8, 97422, Schweinfurt, Germany

    A.G. Rigopoulos, B. Pfeiffer & H. Seggewiss

Authors
  1. A.G. Rigopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Pfeiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Seggewiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A.G. Rigopoulos.

Additional information

Additional material onlineThis article includes fife additional videos. You will find this supplemental at dx.doi.org/10.1007/s00059-013-3794-2.

Electronic supplementary material

59_2013_3794_MO1_ESM.mov

Video 1: Left coronary artery angiography showing the possible target septal branches of the left anterior descending artery for alcohol septal ablation. The special pigtail catheter in the left ventricle as well as the temporary pacing lead in the right ventricle can also be identified. (QuickTime MOV 0,5MB)

59_2013_3794_MO2_ESM.mov

Video 2: Transthoracic echocardiography in the apical 4-chamber view during gelatine succinate injection in the dominant septal branch (No. 1 in Fig. 1). Opacification of the right part of basal septum and the right ventricular papillary muscle. (Fig. 2-1) (QuickTime MOV 0,7MB)

59_2013_3794_MO3_ESM.mov

Video 3: Transthoracic echocardiography in the apical 4-chamber view during gelatine succinate injection in an atypically originating from the left circumflex artery septal branch (No. 2 in Fig. 1). Opacification of part of the basal septum but also of the left ventricular papillary muscle. (Fig 2-2) (QuickTime MOV 0,4MB)

59_2013_3794_MO4_ESM.mov

Video 4: Transthoracic echocardiography in the apical 4-chamber view during gelatine succinate injection in the most proximal small septal branch originating from the left anterior descending artery (No. 3 in Fig. 1). Opacification of a part of the basal septum leaving the point of mitral-septal contact outside the target area. (Fig 2-3) (QuickTime MOV 0,4MB)

59_2013_3794_MO5_ESM.mov

Video 5: Transthoracic echocardiography in the apical 4-chamber view during gelatine succinate injection in the last remaining distal septal branch (No. 4 in Fig. 1). Opacification of the middle septum far from the intended target area (Fig. 2-4). (QuickTime MOV 0,4MB)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rigopoulos, A., Pfeiffer, B. & Seggewiss, H. Serial septal branch assessment in hypertrophic obstructive cardiomyopathy. Herz 39, 219–221 (2014). https://doi.org/10.1007/s00059-013-3794-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-013-3794-2

Search

Navigation